3.34
前日終値:
$3.76
開ける:
$3.72
24時間の取引高:
1.23M
Relative Volume:
1.23
時価総額:
$228.23M
収益:
-
当期純損益:
$-96.66M
株価収益率:
-1.5535
EPS:
-2.15
ネットキャッシュフロー:
$-83.73M
1週間 パフォーマンス:
-20.29%
1か月 パフォーマンス:
-23.57%
6か月 パフォーマンス:
-72.85%
1年 パフォーマンス:
-69.33%
Olema Pharmaceuticals Inc Stock (OLMA) Company Profile
名前
Olema Pharmaceuticals Inc
セクター
電話
(415) 651-3316
住所
780 BRANNAN STREET, SAN FRANCISCO
OLMA を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
OLMA
Olema Pharmaceuticals Inc
|
3.34 | 228.23M | 0 | -96.66M | -83.73M | -2.15 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
484.74 | 124.48B | 11.02B | -535.60M | -978.00M | -2.20 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
617.00 | 67.45B | 14.20B | 4.41B | 3.54B | 38.28 |
![]()
ARGX
Argen X Se Adr
|
567.09 | 34.59B | 2.19B | 833.04M | -1.28B | 12.71 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
255.76 | 33.10B | 2.25B | -278.16M | -42.59M | -2.17 |
![]()
ONC
Beigene Ltd Adr
|
271.04 | 29.15B | 3.81B | -644.79M | -669.77M | -6.24 |
Olema Pharmaceuticals Inc Stock (OLMA) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2024-04-02 | 開始されました | Goldman | Buy |
2024-01-30 | 開始されました | Citigroup | Buy |
2023-07-21 | 開始されました | Oppenheimer | Outperform |
2023-05-05 | 開始されました | CapitalOne | Overweight |
2023-02-22 | 開始されました | Credit Suisse | Outperform |
2022-07-06 | 再開されました | Canaccord Genuity | Buy |
2022-06-09 | アップグレード | H.C. Wainwright | Neutral → Buy |
2022-02-28 | 開始されました | H.C. Wainwright | Neutral |
2021-12-07 | 再開されました | Cowen | Outperform |
2020-12-14 | 開始されました | Canaccord Genuity | Buy |
2020-12-14 | 開始されました | Cowen | Outperform |
2020-12-14 | 開始されました | JP Morgan | Overweight |
2020-12-14 | 開始されました | Jefferies | Buy |
すべてを表示
Olema Pharmaceuticals Inc (OLMA) 最新ニュース
Top Premarket Decliners - MarketScreener
Insiders Could Have Profited By Holding onto Olema Pharmaceuticals Shares Despite 13% Drop - simplywall.st
Olema Pharmaceuticals stock hits 52-week low at $3.86 By Investing.com - Investing.com South Africa
Olema Pharmaceuticals stock hits 52-week low at $3.86 - Investing.com
87,476 Shares in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Acquired by HighTower Advisors LLC - MarketBeat
HighTower Advisors LLC Takes $510,000 Position in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
JPMorgan Chase & Co. Lowers Olema Pharmaceuticals (NASDAQ:OLMA) Price Target to $28.00 - MarketBeat
Pier Capital LLC Acquires New Shares in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Bank of New York Mellon Corp Trims Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
Olema Oncology to Present Preclinical Data for OP-3136, a - GlobeNewswire
Victory Capital Management Inc. Cuts Stock Holdings in Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - MarketBeat
Cancer Breakthrough: New Drug Shows Powerful Anti-Tumor Effects in Prostate, Ovarian, Lung Cancers - Stock Titan
What is Lifesci Capital's Estimate for OLMA FY2025 Earnings? - MarketBeat
HC Wainwright Has Positive Forecast for OLMA Q1 Earnings - MarketBeat
What is HC Wainwright's Forecast for OLMA FY2029 Earnings? - MarketBeat
Olema Pharmaceuticals' (OLMA) "Outperform" Rating Reiterated at Oppenheimer - MarketBeat
HC Wainwright Reaffirms "Buy" Rating for Olema Pharmaceuticals (NASDAQ:OLMA) - MarketBeat
Olema Pharmaceuticals (NASDAQ:OLMA) Releases Earnings Results - MarketBeat
Olema Pharmaceuticals (NASDAQ:OLMA) Posts Quarterly Earnings Results, Beats Estimates By $0.12 EPS - MarketBeat
Victory Capital Management Inc. Sells 758,412 Shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) - Defense World
FY2025 EPS Estimate for Olema Pharmaceuticals Cut by Analyst - Defense World
HC Wainwright Issues Optimistic Outlook for OLMA Earnings - Defense World
Olema Pharmaceuticals Inc (OLMA) Shares Rise Despite Market Challenges - The News Heater
Olema Oncology Reports 2024 Financial and Clinical Progress - TipRanks
Olema Pharmaceuticals (NASDAQ:OLMA) Earns “Outperform” Rating from Oppenheimer - Defense World
HC Wainwright Reiterates “Buy” Rating for Olema Pharmaceuticals (NASDAQ:OLMA) - Defense World
What is HC Wainwright’s Forecast for OLMA FY2029 Earnings? - Defense World
Olema Pharmaceuticals stock hits 52-week low at $3.94 By Investing.com - Investing.com Australia
Olema Pharmaceuticals stock hits 52-week low at $3.94 - Investing.com India
Olema Pharmaceuticals Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Olema Oncology Reports Fourth Quarter and Full Year 2024 Financial and Operating Results - GlobeNewswire
Olema Oncology price target lowered to $25 from $30 at Oppenheimer - TipRanks
Olema Pharmaceuticals Q4 Net Loss Widens -March 18, 2025 at 04:37 pm EDT - Marketscreener.com
Olema Pharmaceuticals Inc Reports Q4 2024 EPS of -$0.63 and Net - GuruFocus.com
Olema Pharmaceuticals, Inc. SEC 10-K Report - TradingView
Olema Pharmaceuticals Inc expected to post a loss of 64 cents a shareEarnings Preview - TradingView
Olema Pharmaceuticals (NASDAQ:OLMA) Receives Buy Rating from HC Wainwright - MarketBeat
Olema Pharmaceuticals’ (OLMA) Buy Rating Reiterated at HC Wainwright - Defense World
Olema Pharmaceuticals stock hits 52-week low at $4.05 - Investing.com
Promising Efficacy of Olema Pharmaceuticals’ Palazestrant Supports Buy Rating - TipRanks
Olema Pharmaceuticals stock hits 52-week low at $4.05 By Investing.com - Investing.com UK
Olema Pharmaceuticals (NASDAQ:OLMA) Given Buy Rating at HC Wainwright - MarketBeat
Olema Pharmaceuticals Inc (OLMA) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):